Clinical Trials Browser

OTHER × Glioma × cabozantinib × Clear all

NCT02885324 2022-10-06

Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children

Phase 2 Terminated

4 enrolled 6 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma